2017
DOI: 10.18632/aging.101280
View full text | Cite
|
Sign up to set email alerts
|

Abstract: Biomarkers of all-cause mortality are of tremendous clinical and research interest. Because of the long potential duration of prospective human lifespan studies, such biomarkers can play a key role in quantifying human aging and quickly evaluating any potential therapies. Decades of research into mortality biomarkers have resulted in numerous associations documented across hundreds of publications. Here, we present MortalityPredictors.org, a manually-curated, publicly accessible database, housing published, st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 34 publications
(38 reference statements)
0
8
0
Order By: Relevance
“…Many clinical measures are associated with all-cause mortality or predict risk of mortality including C-reactive protein (CRP) 16 , red cell distribution width (RDW) 17 , homeostatic model assessment insulin resistance (HOMA-IR) 18 , growth differential factor 15 (GDF15; also known as MIC-1) 19,20 , total white blood cell (WBC) count 21 , serum albumin 22 , serum alkaline phosphatase (ALP), estimated glomerular filtration rate (eGFR), mean cell volume (MCV), triglycerides, cholesterol, elevated blood pressure and elevated body mass index (BMI) 23 . Although progress has been made in identifying and documenting the use of clinical mortality markers, examination of EVs and their cargo in a middle-aged, racially diverse cohort as novel biomarkers of mortality risk could be useful to enhance identification of those at highest risk.…”
Section: Introductionmentioning
confidence: 99%
“…Many clinical measures are associated with all-cause mortality or predict risk of mortality including C-reactive protein (CRP) 16 , red cell distribution width (RDW) 17 , homeostatic model assessment insulin resistance (HOMA-IR) 18 , growth differential factor 15 (GDF15; also known as MIC-1) 19,20 , total white blood cell (WBC) count 21 , serum albumin 22 , serum alkaline phosphatase (ALP), estimated glomerular filtration rate (eGFR), mean cell volume (MCV), triglycerides, cholesterol, elevated blood pressure and elevated body mass index (BMI) 23 . Although progress has been made in identifying and documenting the use of clinical mortality markers, examination of EVs and their cargo in a middle-aged, racially diverse cohort as novel biomarkers of mortality risk could be useful to enhance identification of those at highest risk.…”
Section: Introductionmentioning
confidence: 99%
“…2 Clinical applications of biomarkers generally include prognosticating for individual older patients, identifying high-risk older patients during hospitalisation and helping healthcare workers decide on the best treatment options. 15,16 In this study, we found low systolic blood pressure (SBP < 120 mmHg) and elevated temperature (≥ 39.0°C) to be the independent predictors of all-cause mortality among older medical hospital inpatients.…”
Section: Discussionmentioning
confidence: 58%
“…The effect size of the relationship with mortality (hazard ratios between 1.1 and 1.4 in our cohorts) is comparable to that of existing, clinically-important biomarkers of mortality such as cholesterol (HR=1.12 per mmol/L increase) and systolic blood pressure (HR=1.13 per 10 mm Hg increase) [32, 33]. Importantly, the predictive utility of glucuronic acid persists after adjustment for standard clinical covariates and other accepted predictors of mortality, including factors such as demographics, BMI, smoking status, blood lipids, HbA1c, creatinine, and albumin, indicating that the predictive ability of glucuronic acid for mortality is independent of these existing markers and their related biological mechanisms [34]. Moreover, we have demonstrated novel associations between glucuronic acid levels and future healthspan-related outcomes, including physical abilities, functional capabilities, and self-rated health, suggesting that the risk of mortality associated with elevated glucuronic acid levels is accompanied by a general decline in healthspan.…”
Section: Discussionmentioning
confidence: 99%